Effect of factor VIII on tissue factor-initiated spatial clot growth

Thrombosis and Haemostasis

Volumn 89, Issue 2, 2003, Pages 235-242

  Ovanesov, Mikhail V ^b   Lopatina, Elena G ^b   Saenko, Evgueni L ^a,c   Ananyeva, Natalya M ^a   Ul'yanova, Ljudmila I ^d   Plyushch, Olga P ^b   Butilin, Andrey A ^e   Ataullakhanov, Fazly I ^b,e  

^a HOLLAND LABORATORY   (United States)

^b NATIONAL RESEARCH CENTER FOR HEMATOLOGY   (Russian Federation)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^d INSTITUTE OF IMMUNOLOGY   (Russian Federation)

^e MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

Factor VIII; Fibroblast; Haemophilia A; Spatial clot growth; Time lapse light scattering videomicroscopy

Indexed keywords

BLOOD CLOTTING FACTOR 12A; BLOOD CLOTTING FACTOR 12A INHIBITOR; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING INHIBITOR; CORN TRYPSIN INHIBITOR; THROMBOPLASTIN; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING PARAMETERS; BLOOD CLOTTING TEST; BLOOD CLOTTING TIME; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DISEASE SEVERITY; FIBROBLAST; HEMOPHILIA A; HUMAN; INHIBITION KINETICS; LIGHT SCATTERING; MICROSCOPY; PLASMA TRANSFUSION; PRIORITY JOURNAL;

EID: 0037324245     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613437     Document Type: Article

References (29)

1. Roberts HR, Jones MR. Hemophilia and related conditions - Congenital deficiencies of prothrombin (factor II), factor V, factors VII to XII. In: Hematology, 4th edn. Williams WJ, Beutler E, Erslev AJ, Lichtman M, eds. New York: McGraw-Hill Publishing Co. 1994; 1453-74.
2. Mann KG. Biochemistry and physiology of blood coagulation. Thromb Haemost 1999; 82: 165-74.
3. Rapaport SI, Rao LVM. The tissue factor pathway: How it has become a "prima ballerina". Thromb Haemost 1995; 74: 7-17.
4. Nemerson Y. Tissue factor and hemostasis. Blood 1988; 71: 1-8.
5. Mann KG. Nesheim ME, Church WR, Haley R, Krishnaswamy S. Surface-dependent reactions of the vitamin K-dependent enzyme complexes. Blood 1990; 76: 1-16.
6. Xi M, Beguin S, Hemker HC. Importance of factor-IX-dependent prothrombinase formation - The Josso pathway - In clotting plasma. Haemostasis 1989; 19: 301-8.
7. Cawthern KM, Van't Veer C, Lock JB, DiLorenzo ME, Branda RF, Mann KG. Blood coagulation in hemophilia A and hemophilia C. Blood 1998; 91: 4581-92.
8. He R, Xiong S, He X, Liu F, Han J, Li J, He S. The role of factor XI in a dilute thromboplastin assay for extrinsic coagulation pathway. Thromb Haemost 2001; 85: 1055-9.
9. Repke D, Gemmell CH, Guha A, Turitto VT, Broze GJ Jr, Nemerson Y. Hemophilia as a defect of the tissue factor pathway of blood coagulation: Effect of factors VIII and IX on factor X activation in a continuous-flow reactor. Proc Natl Acad Sci USA 1990; 87: 7623-7.
10. Hoffman M, Monroe DM 3rd. A cell-based model of hemostasis. Thromb Haemost 2001; 85: 958-65.
11. Oliver JA, Monroe DM, Roberts HR, Hoffman M. Thrombin activates factor XI on activated platelets in the absence of factor XII. Arterioscler Thromb Vasc 1999; 19: 170-7.
12. Josso F, Prou-Wartelle O. Interaction of tissue factor and factor VII at the earliest phase of coagulation. Thromb Diath Haemorrh 1965; 17: 35-44.
13. Osterud B, Rapaport SI. Activation of factor XI by the reaction product of tissue factor and factor VII: Additional pathway for initiating blood coagulation. Proc Nat Acad Sci 1977; 74: 5260-4.
14. Gailani D, Broze GJ Jr. Factor XI activation in a revised model of blood coagulation. Science 1991; 253: 909-912.
15. Zarnitsina VI, Pokhilko AV, Ataullakhanov FI. A mathematical model for the spatiotemporal dynamics of the intrinsic pathway of blood coagulation. II. Results. Thromb Res 1996; 84: 333-44.
16. Ataullakhanov FI, Guria GT, Sarbash VI, Volkova RI. Spatiotemporal dynamics of clotting and pattern formation in human blood. Biochim Biophys Acta 1998; 1425: 453-68.
17. Ovanesov MV, Krasotkina JV, Ul'yanova LI, Abushinova KV, Plyushch OP, Domogatskii SP, Vorob'ev AI, Ataullakhanov FI. Hemophilia A and B are associated with abnormal spatial dynamics of clot growth. Biochim Biophys Acta 2002; 1572 (1): 45-57.
18. Morfini M, Lee M, Messori A. The design and analysis of half-life and recovery studies for factor VIII and factor IX. Factor VIII/Factor IX Scientific and Standardization Committee of the International Society for Thrombosis and Haemostasis. Thromb Haemost 1991, 66: 384-6.
19. Kasper CK, Aledort L, Aronson D, Counts R, Edson JR, Van Eys J, Fratantoni J, Green D, Hampton J, Hilgartner M, Levine P, Lazerson J, McMillan C, Penner J, Shapiro S, Shulman NR. Proceedings: A more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorr. 1975; 34: 612.
20. Sinauridze EI, Volkova RI, Krasotkina YV, Sarbash VI, Ataullakhanov FI. Dynamics of clot growth induced by thrombin diffusing into nonstirred citrate human plasma. Biochim Biophys Acta 1998; 1425: 607-16.
21. Mitropoulos KA, Martin JC, Stirling Y, Morrisey JH, Cooper JA. Activation of factors XII and VII induced in citrated plasma in the presence of contact surface. Thromb Res 1995; 78: 67-75.
22. Muller AD, Van Deijk WA, Devilee PP, Van Dam-Mieras MC, Hemker HC. The activity state of factor VII in plasma: Two pathways for the cold promoted activation of factor VII. Br J Haematol 1986; 62: 367-77.
23. Hojima Y, Pierce JV, Pisano J. Hageman factor fragment inhibitor in corn seeds: Purification and characterization. Thromb Res. 1980; 20: 149-62.
24. Saenko EL, Shima M, Gilbert GE, Scandella D. Slowed release of thrombin-cleaved factor VIII from von Willebrand factor by a monoclonal and a human antibody is a novel mechanism for factor VIII inhibition. J Biol Chem 1996; 271: 27424-31.
25. Krasotkina YV, Sinauridze EI, Ataullakhanov FI. Spatiotemporal dynamics of fibrin formation and spreading of active thrombin entering non-recalcified plasma by diffusion. Biochim Biophys Acta 2000; 1474: 337-45.
26. Nilsson IM. Replacement therapy. In: Hemophilia. Nilsson IM, Brenshop E, Lethagen S, Ljung R and Peterson C, eds. Pharmacia, Plasma Products 1994; 48-65.
27. Singh I, Smith A, Vanzieleghem B, Collen D, Burnand K, Saint-Remy JM, Jacquemin M. Antithrombotic effects of controlled inhibition of factor VIII with a partially inhibitory human monoclonal antibody in a murine vena cava thrombosis model. Blood May 1 99 (9): 3235-40.
28. Marlar RA, Kleiss AJ, Griffin JH. An alternative extrinsic pathway of human blood coagulation. Blood 1982, 60: 1353-8.
29. Moroe DM, Hoffman M, Roberts HR. Transmission of a procoagulant signal from tissue factor-bearing cells to platelets. Blood Coagul Fibrinolysis. 1996; 7: 459-64.